laninamivir octanoate

 

Topic mentions per year

Topic mentions per year

2010-2018
02420102018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
The clinical outcome of laninamivir octanoate hydrate (laninamivir) in the Japanese 2013-2014 influenza season was investigated… (More)
Is this relevant?
2014
2014
Background: Laninamivir octanoate (LO), an inhaled neuraminidase inhibitor, has been used against influenza in Japan. However… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2013
2013
Laninamivir octanoate, a long-acting neuraminidase inhibitor, is an effective treatment for influenza. However, its effectiveness… (More)
  • figure 1
  • table 1
  • figure 2
  • table 3
Is this relevant?
2013
2013
Laninamivir octanoate (LO) (Inavir; Daiichi Sankyo, Japan) is an ester prodrug of the neuraminidase inhibitor laninamivir. We… (More)
  • table 1
  • table 2
Is this relevant?
2012
2012
A single inhaled dose of laninamivir octanoate (LO), a long-acting neuraminidase inhibitor, exhibits efficacy in treating both… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
Is this relevant?
2012
2012
OBJECTIVE The purpose of this study was to compare the efficiency and safety of a new neuraminidase inhibitor, laninamivir… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
Is this relevant?
2012
2012
BACKGROUND Patients with influenza virus infection can develop severe pneumonia and acute respiratory distress syndrome (ARDS… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2011
2011
The 2009 H1N1 influenza pandemic (pH1N1) led to record sales of neuraminidase (NA) inhibitors, which has contributed… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
Is this relevant?
Highly Cited
2010
Highly Cited
2010
We conducted a double-blind, randomized controlled trial to compare a long-acting neuraminidase inhibitor, laninamivir octanoate… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2010
2010
BACKGROUND A single administration of laninamivir octanoate, a long-acting neuraminidase inhibitor, against influenza infection… (More)
  • figure 1
  • table 1
  • figure 2
Is this relevant?